Nitin Kaushal

Forbes Medi-Tech, Inc. develops and markets a portfolio of nutraceutical products, including functional foods and supplement for the benefit of all consumers. The company provides value-added products and cholesterol-lowering ingredients for use in functional foods and dietary supplements. Rewrite as 'It is a life sciences company focused on evidence-based nutritional solutions. It has successfully developed and commercialized its Reducol(tm) plant sterol blend, which has undergone clinical trials in various matrices and has been shown to lower 'LDL' cholesterol levels safely and naturally. It was founded on September 17, 1985 and is headquartered in Vancouver, Canada

Medwell Capital Corp. operates as an investment and advisory firm which directly invests in and advises companies on strategy and corporate and technology development. It also provides clinical, regulatory and corporate advisory services. The company was founded on December 15, 1998 and is headquartered in Edmonton, Canada.

Victhom Laboratory, Inc. is a company which owns patents in the field of orthotics and prosthetics including intellectual property used in the Power Knee. Victhom Laboratory was founded on January 11, 2002 and is headquartered in Montreal, Canada.

Sophiris Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of products for the treatment of urological diseases. The company was founded by James L. Heppell in May 2003 and is headquartered in La Jolla, CA.

SVT Capital Corp. is an exploration stage company, which engages in the acquisition and exploration of oil and gas and mineral properties The company was founded on May 16, 2001 and is headquartered in Vancouver, Canada.

PricewaterhouseCoopers Corporate Finance LLC provides financial advisory services. The company is headquartered in Chicago, IL.

Genizon Biosciences Inc. discovers genes and biomarkers in common diseases using genome wide association studies (GWAS), leveraging its proven and proprietary technology platform and access to patients from the Quebec Founder Population. Genizon has one of the largest GWAS programs worldwide, addressing many common diseases and traits. Several of these have been successfully completed, generating comprehensive maps of interacting genes, biomarkers and biological disease pathways (known as GeneMaps), providing strong validation of the power of the Company's discovery platform. Genizon has out-licensed some of the therapeutic and diagnostic rights to GeneMaps for Crohn's disease (to Genentech) and attention deficit hyperactivity disorder, endometriosis and Alzheimer's disease (disease-state diagnostic rights to Pfizer). GeneMaps have also been generated from GWAS in schizophrenia, psoriasis and longevity. GWAS are in progress for rheumatoid arthritis, Alzheimer's disease, and coronary heart disease and its precursors, obesity, type II diabetes, dyslipidemia and hypertension (collectively metabolic syndrome). Genizon's technology platform and discoveries can complement current R&D programs by using human genetics to significantly enhance research and by adding value at multiple stages of the drug development process. Genizon is continually developing and enhancing its gene and biomarker discovery platform. For example, the company is assessing the role of copy number variations (CNVs) in diseases- applying new methods to ongoing large-scale GWAS in rheumatoid arthritis and metabolic syndrome, and retrospectively to previous studies. Genizon also leverages its platform and expertise by offering high throughput, high quality SNP genotyping, statistical genetics, gene expression and pharmacogenomics services to academic institutions, research organizations and the biopharmaceutical industry.

Founded in 1969, HSBC Securities (U.S.A.) Inc. is an SEC-registered brokerage firm and registered futures commission merchant located in New York City. The firm is a wholly-owned subsidiary of HSBC North America Holdings, Inc. and their ultimate parent is HSBC Holdings Plc. (NYSE: HBC). HSBC Securities (U.S.A.) is a member of FINRA, the NYSE and the SIPC. Their securities and annuity products are provided by registered representatives and insurance agents of HSBC Securities (U.S.A.). In California, HSBC Securities (U.S.A.) conducts insurance business as HSBC Securities Insurance Services. Insurance products are offered through insurance agents of HSBC Insurance Agency (U.S.A.) Inc., a wholly-owned subsidiary of HSBC Bank U.S.A. NA and an indirectly wholly-owned subsidiary of HSBC Holdings plc. The company also engages in investment banking underwriting, dealing and brokering of debt and equity securities and futures contracts and is a primary dealer in U.S. Government and federal agency securities.

Shelby Ventures, Inc. operates as a capital pool company. Its principal business is to identify and evaluate opportunities for the acquisition of an interest in assets or businesses. The company was founded on February 27, 2007 and is headquartered in Vancouver, Canada.

DRM Ventures, Inc. provides investment services. The company was founded on August 24, 2009 and is headquartered in Toronto, Canada.

Lumira Capital Investment Management is a Venture Capital firm, a subsidiary of Nordion (Canada),Inc. founded in 1989 by Tony Pullen. The firm is headquartered in Toronto.

Orion Securities, Inc. is an independent broker/dealer headquartered in Toronto with additional offices in Calgary and Montréal and Chicago. The firm provides research, trade execution, underwriting and advisory services. Orion's research team focuses on mining, energy, healthcare, biotechnology, technology and diversified industries. They focus primarily on Canadian-based stocks

Desjardins Securities, Inc. is the broker/dealer arm of the Desjardins Holding Financier, Inc., ultimately held by Le Mouvement des caisses Desjardins in Canada. Founded in 1991, the firm is headquartered in Montréal and has an additional office in Toronto. Desjardins Securities offers businesses and institutions with a complete range of securities brokerage products and services through its investment advisors and its Disnat Online Brokerage division. The firm is an approved participant on the Montreal Exchange and the Toronto Stock Exchange, as well as a participating member of the TSX Venture Exchange. In addition, Desjardins Securities is a member of both the Investment Industry Regulatory Organization of Canada (IIROC) and the Canadian Investor Protection Fund (CIPF).

Part of iA Financial Corp., Inc., Vengate Capital Partners is a Canadian company that provides financial advisory services to life and science companies. The company is based in Toronto, Canada. Vengate Capital Partners was acquired by MGI Securities, Inc. on November 03, 2004.

Amadeus International, Inc. operates as a development stage company. It focuses on the marketing of software solutions, such as enterprise quality resource planning, and enterprise quality & compliance management. The company was founded on December 22, 2004 and is headquartered in Quebec, Canada.

PricewaterhouseCoopers LLP provides accounting services. The firm provides industry focused assurance, advisory and tax services for public, private and government clients in four areas such as corporate accountability, risk management, structuring and mergers and acquisitions and performance and process improvement. Its services include consulting, deals, risk assurance services and insolvency assignments. The company was founded on July 1, 1998 and is headquartered in Toronto, Canada.

Founded in 2000, MGI Securities, Inc., formerly McFarlane Gordon, Inc., is a broker/dealer headquartered in Toronto with an additional office in Calgary. The firm is a subsidiary of Jovian Capital Corp. (TSX: JVN). They provide a range of specialized services for institutional investors and professional private wealth management solutions for individual investors. MGI Securities does not provide any internal research. MGI Securities is a member of the Investment Industry Regulatory Organization of Canada (IIROC) and the Canadian Investor Protection Fund (CIPF). The firm is a participating organization in the Toronto Stock Exchange, the TSX Venture Exchange and the Canadian Trading and Quotation System Inc. (CNQ) through their PURE Trading Facility, Alpha Trading Systems, Omega ATS and Chi-X Canada.

Canadian Institute of Chartered Accountants engages in the provision of accounting, auditing, tax, advisory, and professional services. The institute is headquartered in Toronto, Canada.

Mimetogen Pharmaceuticals, Inc. develops peptidomimetic small molecule drugs against glaucoma and cancer. Its product mimic the effects of neurotrophin proteins that help to maintain the health and growth of cells and tissues found in the eye. Mimetogen provides tyrosine kinase agonists that prevent neuronal death; small molecule tyrosine kinase receptor agonists, which stimulates mucin secretion from conunctival goblet cells; and small molecule neurotrophin mimetics that rescues retinal pigment epithelial cells from oxidative stress-induced apoptosis. The company was founded by Garth Cumberlidge and H. Uri Saragovi in 2005 and is headquartered in Montreal, Canada.

Fe Pharmaceuticals (Canada), Inc. operates as a research institution. It offers indication & treatment challenge, technical innovation and market services. The company was founded by William M. Cheliak and Bruce Holbein and is headquartered in Halifax, Canada.

Global Gardens Group, Inc. engages in the manufacture and sale of dairy-free natural food products. It offers products under the Veggemo brand. The company was founded on November 11, 2014 and is headquartered in Richmond, Canada.

Delivra Corp. operates as a biotechnology company, which engages in the manufacture and sale of natural topical creams under the LivRelief brand. It also develops transdermal technologies for the delivery of pharmaceutical and natural molecules, through the skin, rather than via pills. The company was founded on July 19, 2007 and is headquartered in Hamilton, Canada.

Valens Co., Inc. is a cannabis consumer products company, which engages in the development and manufacturing of cannabis products developed from the firm's proprietary extraction techniques. The company was founded on January 14, 1981 and is headquartered in Ontario, Canada.

Hyasynth Biologicals, Inc. manufactures natural cannabinoid compounds. It offers researchers, doctors, and patients with options in treating multiple sclerosis, epilepsy (dravet syndromes), Alzheimer’s diseases, chronic pains, inflammations, and muscular dystrophy diseases. The company was founded by Alex Campbell, Kevin Chen, Shoham Mookerjee, Sarah Choukah and Zach Wiltshire and is headquartered in Montreal, Canada.

Delta 9 Bio-Tech LP provides medicinal cannabis products. The company was founded by John Arbuthnot and Bill Arbuthnot in 2013 and is headquartered in Winnipeg, Canada.

HashChain Technology, Inc. is a blockchain technology company, which engages in cryptocurrency mining, cryptocurrency accounting, and Masternode hosting services. The company was founded by Patrick Gray on February 18, 2017 and is headquartered in Albany, NY.

ChemioCare, Inc. engages in the development and manufacture of pharmaceutical products. The company was founded in 2017 and is headquartered in New York, NY.

Beejapuri Dairy Pvt Ltd. manufactures fresh buffalo and cow milk. The firm brings natural, fresh and unadulterated cow and buffalo milk directly to doorstep. The company was founded by Chakradhar Gade and Nitin Kaushal in 2013 and is headquartered in Gurugram, India.

Delivra, Inc. provides digital marketing software and services by email. The firm services include email marketing, strategy, design and reporting. The company was founded by Neil Berman in 1999 and is headquartered in Indianapolis, IN.

Starton Therapeutics, Inc. is a clinical-stage biotechnology platform company that focuses on transforming standard of care therapies with proprietary continuous delivery technology. The company is based in Paramus, NJ. The company's goal is to provide continuous treatment to people with cancer so they can live better and longer. Starton's proprietary transdermal technology is intended to increase the efficacy of approved drugs, make them more tolerable, and expand their potential use. The company was founded in 2017 by Pedro Lichtinger, who has been the CEO since 2017.